About NeuroSigma
NeuroSigma is a company based in Los Angeles (United States) founded in 2008 by Leon Ekchian. NeuroSigma has raised $2.92 million across 12 funding rounds from investors including KT, HHS and Checkmate Capital. The company has 8 employees as of December 31, 2019. NeuroSigma offers products and services including Monarch eTNS System. NeuroSigma operates in a competitive market with competitors including Muse, Flow Neuroscience, Freespira, Feel Therapeutics and HypnoVR, among others.
- Headquarter Los Angeles, United States
- Employees 8 as on 31 Dec, 2019
- Founders Leon Ekchian
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurosigma, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.92 M (USD)
in 12 rounds
-
Latest Funding Round
$5 M (USD), Post-IPO
Dec 08, 2021
-
Investors
KT
& 3 more
-
Employee Count
8
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroSigma
NeuroSigma offers a comprehensive portfolio of products and services, including Monarch eTNS System.
FDA-cleared device for treating pediatric ADHD via nerve stimulation.
People of NeuroSigma
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroSigma
NeuroSigma has successfully raised a total of $2.92M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NeuroSigma
NeuroSigma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include KT, HHS and Checkmate Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Checkmate Capital is backed by family office for private equity.
|
Locked | Locked | Locked | |
|
Provider of voice, data, and internet services
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for NeuroSigma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuroSigma
Investment portfolio details for NeuroSigma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuroSigma
Detailed financials for NeuroSigma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurosigma Comparisons
Peer comparison for NeuroSigma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuroSigma
NeuroSigma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Muse, Flow Neuroscience, Freespira, Feel Therapeutics and HypnoVR, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
EEG-powered headbands for meditation and sleep biofeedback are developed.
|
|
| Locked | Locked | Locked |
Provider of a wearable device for stress and anxiety management
|
|
| Locked | Locked | Locked |
Panic disorders are treated via breathing device and mobile app.
|
|
| Locked | Locked | Locked |
Provider of digital Precision Medicine company leveraging objective data and passive measurement for mental healthcare
|
|
| Locked | Locked | Locked |
Virtual reality therapies for pain and anxiety reduction are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive bioelectronics are developed for mental health disorders.
|
Detailed competitors of NeuroSigma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurosigma
Complete news archive for NeuroSigma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroSigma
NeuroSigma was founded in 2008 and raised its 1st funding round 2 years after it was founded.
NeuroSigma is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Leon Ekchian is the current CEO of NeuroSigma. They have also founded this company.
NeuroSigma is a funded company, having raised a total of $2.92M across 12 funding rounds to date.
As of Dec 31, 2019, the latest employee count at NeuroSigma is 8.
NeuroSigma was founded in 2008 and is based in Los Angeles, United States. Operations center on the medical device sector, with trigeminal nerve stimulation (TNS) technology commercialized for conditions such as epilepsy, depression, ADHD, and PTSD. A pipeline of treatments is advanced through preclinical research, development, and clinical trials spanning Phases I, II, and III.
NeuroSigma's top competitors include Muse, Hapbee and Motif neurotech.
NeuroSigma offers Monarch eTNS System.
NeuroSigma has 4 investors. Key investors include KT, HHS, Checkmate Capital, and National Institute of Neurological Disorders and Stroke.